Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer

Clinical trial NCT03703063 · UNKNOWN

Trial details

NCT number: NCT03703063
Sponsor: Benaroya Research Institute
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma

Start date: 2018-09-17
Primary completion: 2021-09-17
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.